Wang Xiaofang, Li Yangqiu
Department of Hematology, First Affiliated Hospital, School of Medicine, Jinan University.
Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
Blood Sci. 2019 Sep 17;1(1):88-91. doi: 10.1097/BS9.0000000000000001. eCollection 2019 Aug.
Human adult hematopoiesis maintains homeostasis by replacing depleted progeny pools and inducing a primary immune response to infectious diseases and tumors. Recent studies have shown that tumor progression is associated with profound perturbations in hematopoiesis. Scientists have sought to clarify the complex mechanisms underlying the developmental fate of hematopoiesis by assessing hematopoietic stem and progenitor cells in various tumors. Results have shown that tumors disrupt normal hematopoiesis, resulting in extramedullary hematopoiesis and myeloid skewing. The key regulatory roles played by myeloid-derived suppressor cells induce immune suppression. Here, we summarize recent findings and discuss mechanisms underlying the disruption of hematopoiesis in solid tumors.
人类成年造血通过补充耗尽的子代池以及对传染病和肿瘤引发初级免疫反应来维持体内平衡。最近的研究表明,肿瘤进展与造血过程中的深刻扰动有关。科学家们试图通过评估各种肿瘤中的造血干细胞和祖细胞来阐明造血发育命运背后的复杂机制。结果表明,肿瘤会破坏正常造血,导致髓外造血和髓系偏向。髓系来源的抑制细胞所起的关键调节作用会诱导免疫抑制。在此,我们总结了最近的研究发现,并讨论实体瘤中造血破坏的潜在机制。